Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.13 CAD
Change Today +0.01 / 8.33%
Volume 534.6K
MOM On Other Exchanges
Symbol
Exchange
Venture
OTC US
As of 3:59 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

miraculins inc (MOM) Snapshot

Open
C$0.13
Previous Close
C$0.12
Day High
C$0.13
Day Low
C$0.12
52 Week High
08/14/14 - C$0.37
52 Week Low
03/31/15 - C$0.09
Market Cap
5.6M
Average Volume 10 Days
1.6M
EPS TTM
C$-0.09
Shares Outstanding
43.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MIRACULINS INC (MOM)

Related News

No related news articles were found.

miraculins inc (MOM) Related Businessweek News

No Related Businessweek News Found

miraculins inc (MOM) Details

Miraculins Inc., a medical diagnostic company, focuses on acquiring, development, and commercialization of non-invasive technologies for unmet clinical needs in Canada. The company's PreVu non-invasive skin cholesterol test, a coronary artery disease risk assessment technology that measures cholesterol levels in a patient's skin; and SCOUT DS system, a non-invasive diabetes screening system designed to provide sensitive and convenient method for screening for pre-diabetes and type 2 diabetes based on the presence of diabetes-related biomarkers found in skin. It also develops preeclampsia diagnostic test for preeclampsia, a pregnancy specific disease; and offers testing services. The company was incorporated in 1998 and is headquartered in Winnipeg, Canada.

Founded in 1998

miraculins inc (MOM) Top Compensated Officers

Chief Executive Officer, President and Non In...
Total Annual Compensation: C$247.9K
Chief Financial Officer
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

miraculins inc (MOM) Key Developments

Miraculins Inc. Auditor Raises 'Going Concern' Doubt

Miraculins Inc. filed its Annual on Mar 27, 2015 for the period ending Nov 30, 2014. In this report its auditor, KPMG LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Miraculins Inc. Appoints Dr. Alain Sotto to the Scout DS(R) Medical Advisory Board

Miraculins Inc. announced that it has appointed Dr. Alain Sotto, Hon. B.Sc., M.D., CCFP (E.M.), F.C.B.O.M to the Scout DS(R) Medical Advisory Board. Dr. Sotto is the Toronto Transit Commission's Occupational Medical Consultant, Investigative Coroner for York Region, and Director of the Medcan Wellness Clinic.

Miraculins Reports on Positive Results as First Pharmacy Pilot for the Scout Ds® Diabetes Screening Kiosk Nears Completion

Miraculins Inc. announced that its Scout ® DS Diabetes Screening Kiosk pilot being conducted in partnership with Lovell Drugs Ltd. and Pear Healthcare Solutions Inc., has to date identified 145 individuals, or 41% of those screened in just 16 days, to be at elevated risk for pre-diabetes or type 2 diabetes. All customers who were ® identified as being at risk by the Scout DS were recommended to follow-up with their physician for confirmatory blood testing. The company also reported that pilot participants were pleased to complete a touch-screen survey ® while seated for their complimentary and non-invasive Scout DS diabetes test, which resulted in the acquisition of valuable and traditionally difficult to procure consumer information. The survey was specifically tailored to help identify opportunities for the provision of enhanced healthcare and customer service, while isolating pathways for the pharmacy to potentially increase its revenues related to diabetes care and corresponding lifestyle change management. Both the screening and survey were preceded by participating individuals signing a consent form.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MOM:CN C$0.13 CAD +0.01

MOM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Health Discovery Corp $0.02 USD 0.00
Imperial Innovations Group PLC 470.00 GBp -2.50
MDxHealth €5.04 EUR +0.037
Myriad Genetics Inc $33.59 USD -0.77
Vermillion Inc $1.80 USD -0.04
View Industry Companies
 

Industry Analysis

MOM

Industry Average

Valuation MOM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 187.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 138.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MIRACULINS INC, please visit www.miraculins.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.